Probiotic industry value set to reach £29bn

By Nicholas Robinson

- Last updated on GMT

The effects of bacteria on the gut will be discussed at the conference
The effects of bacteria on the gut will be discussed at the conference

Related tags Gut flora Nutrition Probiotic

Sales of probiotic food, drink and supplements are set to reach £29bn by 2018, as consumers seek food-based answers to health issues, according to one expert commentator.

The market and the latest science in the field, will be discussed at the eighth Probiota conference in Amsterdam, which is arranged by’s sister title

“Probiota bridges the gap between scientific discovery and commercial application,” ​said and senior editor Shane Starling.

“The global market for probiotic food, beverages and supplements is growing strongly, valued at £19bn in 2013 and is expected to reach £29bn by 2018,” ​he added.

‘Products they can trust’

“Consumers are looking for products they can trust to support a range of conditions, from digestive health to cholesterol management, immune system and brain health.”

At the conference, leading academics from across the world will present various studies on subjects such as the effects of probiotics on pregnancy and in early life.

Graham Rook, who is a professor of medical microbiology at University College London, will connect probiotics with microbiota (also known as gut flora), gut inflammation, low stress resistance and psychiatric disorders.

Probiota looks set to attract substantial interest from experts, despite the fact the term probiotic is not recognised in Europe under its Nutrition & Health Claims Regulation. This means products, such as yogurts and yogurt drinks, cannot be labelled with the term.

However, the power of consumer testimonials has allowed the market to thrive in Europe, as well as across the world, Starling added.

‘Large globally’

“The probiotic market is large globally because consumers have consumed them for years and many attain benefits from them, so there is that anecdotal link,” ​Starling added.

The market’s success had also been fuelled by the large amounts of research available about probiotics. In addition, the European Food Safety Authority’s (EFSA’s) refusal to approve a health claim didn’t mean there were no health benefits in a product rejected in an application, he added.

Italy had already caused a stir in the industry by attempting to use the term probiotic as a ‘generic descriptor’ said Starling, and if it was successful in getting the approval to do so, the term could make a re-appearance on pots of yogurt​ on sale in UK supermarkets.

Probiota will take place between February 3–5 this year at the NH Grand Hotel Krasnapolsky in Amsterdam.

To find out more and to book your place at the conference, click here

Related products

show more

Elevate your snacks with novel cheese flavours

Elevate your snacks with novel cheese flavours

Content provided by Givaudan | 23-Feb-2024 | Product Brochure

Aside from conducting desk research to understand snacking preferences and taste profiles among consumers in the Asia Pacific, Givaudan also embarked on...

Empowering Women Through the Life Cycle

Empowering Women Through the Life Cycle

Content provided by Glanbia Nutritionals | 07-Nov-2023 | Product Brochure

As discussions around female empowerment widen, and advances in women’s health access and provision accelerate, the implications for business, healthcare,...

Analyzing the unknown threat from Microplastics

Analyzing the unknown threat from Microplastics

Content provided by Agilent Technologies | 06-Nov-2023 | Infographic

Microplastics are any plastic-derived synthetic solid particle or polymeric matrix, ranging in size from 1 µm to 5 mm and insoluble in water.

Related suppliers

Follow us


View more


Food & Beverage Trailblazers

F&B Trailblazers Podcast